Figure 1.
Expression of NRP1 in tumors using the UALCAN database analysis. Expression of NRP1 in (A) HNSC, (B) KIRC, (C) LIHC, (D) THCA and (E) STAD samples based on sample types of normal and primary tumor TCGA samples. (F) Expression of NRP1 in TGCTs based on tumor histology of seminoma and non-seminoma TCGA samples. Expression of NRP1 in HNSC based on the (G) tumor grade and (H) individual cancer stages in TCGA samples. Expression of NRP1 in STAD samples based on the (I) tumor grade and (J) individual cancer stages in TCGA samples. Grade 1, well differentiated (low grade); grade 2, moderately differentiated (intermediate grade); grade 3, poorly differentiated (high grade); grade 4, undifferentiated (high grade). **P<0.01 vs. Normal; ##P<0.01 vs. Grade 1 or Stage 1; ~~P<0.01 vs. Grade 2 or Stage 2; ^^P<0.01 vs. Grade 3 or Stage 3. NRP1, neuropilin 1; HNSC, head and neck squamous cell carcinoma; KIRC, kidney renal clear cell carcinoma; LIHC, liver hepatocellular carcinoma; THCA, thyroid carcinoma; STAD, stomach adenocarcinoma; TCGA, The Cancer Genome Atlas; TGCT, testicular germ cell tumor.